| LN&Planting (N=53) |
Planting (N=39) |
P-value | |
|---|---|---|---|
| Age | |||
| Mean (SD) | 55.5 (9.75) | 55.3 (11.4) | 0.367 |
| Median [Min, Max] | 56.0 [24.0, 79.0] | 54.0 [28.0, 82.0] | |
| Operation_history | |||
| Direct_surgery | 29 (54.7%) | 30 (76.9%) | 0.0295 |
| Septal_tumor_reduction | 0 (0%) | 1 (2.6%) | |
| Surgery_after_neoadjuvant | 24 (45.3%) | 8 (20.5%) | |
| Type | |||
| CCC | 1 (1.9%) | 1 (2.6%) | 0.572 |
| EC | 1 (1.9%) | 1 (2.6%) | |
| HGSC | 48 (90.6%) | 36 (92.3%) | |
| LGSC | 2 (3.8%) | 0 (0%) | |
| MC | 0 (0%) | 1 (2.6%) | |
| Missing | 1 (1.9%) | 0 (0%) | |
| Clinical_stage | |||
| I | 0 (0%) | 0 (0%) | NA |
| II | 0 (0%) | 7 (17.9%) | |
| III | 19 (35.8%) | 24 (61.5%) | |
| IV | 34 (64.2%) | 8 (20.5%) | |
| Planting_metastasis | |||
| No | 0 (0%) | 0 (0%) | NA |
| Yes | 53 (100%) | 39 (100%) | |
| Lymph.node_metastasis | |||
| No | 0 (0%) | 39 (100%) | <0.001 |
| Yes | 53 (100%) | 0 (0%) | |
| TMB_group | |||
| High | 3 (5.7%) | 2 (5.1%) | 1 |
| Low | 48 (90.6%) | 37 (94.9%) | |
| Missing | 2 (3.8%) | 0 (0%) | |
| Relapse_within_6months | |||
| Yes | 8 (15.1%) | 4 (10.3%) | 0.514 |
| No | 35 (66.0%) | 24 (61.5%) | |
| Unknown | 10 (18.9%) | 11 (28.2%) |